Purple Innovation, Inc. current report, 21 February 2017

SEC Filing Summary: Global Partner Acquisition Corp. (GPAC)

Business Context and Reporting Period

This Form 8-K was filed on February 21, 2017, by Global Partner Acquisition Corp. (GPAC), a Delaware corporation. The filing serves as a Regulation FD disclosure to provide an updated investor presentation (Exhibit 99.1) regarding a previously announced proposed business combination with Sequel Youth and Family Services, LLC ("Sequel"). The transaction is governed by an Agreement and Plan of Merger.

Key Financial Metrics

The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either GPAC or Sequel. This document is a procedural filing to distribute an investor presentation rather than a financial report containing audited or unaudited financial statements.

Material Changes

The material change disclosed is the release of an updated investor presentation to be used in communications with stockholders regarding the proposed merger with Sequel. No operational or financial changes are detailed within the text of this specific filing.

Guidance, Outlook, and Risks

Outlook and Forward-Looking Statements: The filing contains extensive forward-looking statements regarding the timing of the business combination, future business plans, and expected results of operations post-merger. Management cautions that actual results may differ materially from projections.

Key Risks and Contingencies:

  • Transaction Completion: Risks include failure to obtain stockholder approval, termination of the Merger Agreement, or failure to meet closing conditions.
  • Regulatory and Legal: Potential legal proceedings, government investigations, and changes in healthcare laws (specifically regarding the Affordable Care Act and Medicaid spending).
  • Operational: Risks related to care incidents, billing practices, cybersecurity, and the ability to recruit key personnel.
  • Market: Intense competition, consolidation of managed-care organizations, and the inability to profitably expand into new markets.

Investor Action: Investors are advised to read the preliminary proxy statement filed on January 25, 2017, and the upcoming definitive proxy statement for detailed information on the transaction.

Important Facts for Investor Verification

  • Verify the terms of the Merger Agreement and the proposed business combination in the definitive proxy statement.
  • Review the updated investor presentation (Exhibit 99.1) for specific financial projections and strategic plans not included in this text.
  • Monitor the status of stockholder approval required to consummate the merger with Sequel.
  • Assess the impact of potential regulatory changes to the Affordable Care Act and Medicaid on Sequel's future revenue streams.
  • Confirm the listing status of GPAC's common stock and warrants on The NASDAQ Capital Market post-transaction.